These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 25400446)

  • 1. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome and bacterial translocation in cirrhosis.
    Gómez-Hurtado I; Such J; Francés R
    Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
    Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microflora in the pathogenesis of the complications of cirrhosis.
    Garcia-Tsao G; Wiest R
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):353-72. PubMed ID: 15123075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
    Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
    World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.
    Bellot P; Francés R; Such J
    Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis.
    Ramachandran A; Balasubramanian KA
    J Gastroenterol Hepatol; 2001 Jun; 16(6):607-12. PubMed ID: 11422611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
    Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A
    World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotics can ameliorate circulatory complications of liver cirrhosis].
    Madsen BS; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial translocation and its consequences in patients with cirrhosis.
    Guarner C; Soriano G
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):27-31. PubMed ID: 15647636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and probiotics in chronic liver diseases.
    Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
    Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota and the liver: implications for clinical practice.
    Quigley EM; Monsour HP
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):723-32. PubMed ID: 24134195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.
    Lachar J; Bajaj JS
    Semin Liver Dis; 2016 Sep; 36(4):327-330. PubMed ID: 27997972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection as a Trigger for Portal Hypertension.
    Steib CJ; Schewe J; Gerbes AL
    Dig Dis; 2015; 33(4):570-6. PubMed ID: 26159275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
    Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
    Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
    Qamar AA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
    Madsen BS; Havelund T; Krag A
    Adv Ther; 2013 Jul; 30(7):659-70. PubMed ID: 23881723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.